Pure Biologics is a biopharmaceutical company focused on the biological drug discovery and development. We operate in the areas of immuno-oncology conducting research based on our own technology platform for the selection of active molecules – antibodies.
Pure Biologics has been operating on the market since 2010. Its headquarters is located in Wrocław, Poland. Main areas of activity include biotechnology, biological drug discovery and modern therapeutic solutions based on antibodies. In two key projects the Company has completed all steps in the drug development process – from target selection and validation to preclinical studies – and has directed them to phase 0 clinical trials.
Pure Biologics’ therapeutic portfolio includes new immunooncology therapies. It is a total of a dozen projects, including two key projects in which we use antibody technologies to develop molecules with therapeutic potential.
Our projects are a continual source of novel ideas, solutions, and interesting scientific results, which we translate into new therapies for patients in greatest need. Uniqueness and innovation of these results are best evidenced by original publications and other studies, which we regularly present at conferences and scientific seminars.
We bet on stable and balanced development in all key operation areas – our therapeutic portfolio, scientific and business expertise and networking. Our plans envisage achieving financial independence and profits by commercializing therapeutic candidates, allowing us to pursue our next, advanced ideas.
